Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription Articles published in Biol Psychiatry Retrieve available abstracts of 122 articles: HTML format

Single Articles

December 2026
1. GORDILLO D, Baradarantohidi E, Grent-'t-Jong T, Uhlhaas PJ, et al
   Linking Circuit Deficits With Electroencephalography Through Computational Modeling for Psychosis Prediction.
   Biol Psychiatry. 2026;100:1064-1066.
   PubMed    
   
   
   
2. RAEDLER TJ
   The Muscarinic Hypothesis of Schizophrenia Revisited.
   Biol Psychiatry. 2026;100:1062-1063.
   PubMed    
   
   
   
3. GRACE AA, Uliana DL
   Antipsychotic Drug Action, Novel Treatment Targets, and the Failure of Current Clinical Trial Designs in Evaluating New Target Molecules.
   Biol Psychiatry. 2026;100:1078-1088.
   PubMed     Abstract available
   
   
   October 2026
4. VIEIRA S, Aleman Y, Bici L, Meijer J, et al
   Positive-affective and negative-cognitive brain-behavior axes in clinical high risk for psychosis.
   Biol Psychiatry. 2026 Oct 23:S0006-3223(26)01614.
   PubMed     Abstract available
   
   
   
5. HUANG H, Palaniyappan L, Li H, Zhou J, et al
   Thalamocortical dysconnectivity shapes cortical hierarchy disruption across illness durations in schizophrenia.
   Biol Psychiatry. 2026 Oct 21:S0006-3223(26)01613.
   PubMed     Abstract available
   
   
   
6. SLIFSTEIN M, Gil R, Weinstein J, Van Snellenberg J, et al
   Simultaneous measurement of Midbrain and Striatal Dopamine in Schizophrenia using an agonist radiotracer.
   Biol Psychiatry. 2026 Oct 21:S0006-3223(26)01612.
   PubMed     Abstract available
   
   
   
7. SIMONS NW, Patel V, Li H, Iyer S, et al
   Development of a messenger RNA therapy for schizophrenia.
   Biol Psychiatry. 2026 Oct 12:S0006-3223(26)01589.
   PubMed     Abstract available
   
   
   September 2026
8. TROTTA G, Austin-Zimmerman I, Spinazzola E, Haussler S, et al
   Gene-Environment Correlation Across Trauma Subtypes and Developmental Timing: Evidence From the EU-GEI and ALSPAC.
   Biol Psychiatry. 2026;100:638-647.
   PubMed     Abstract available
   
   
   August 2026
9. TORRES-CARMONA E, Graff-Guerrero M, Nakajima S, Iwata Y, et al
   Machine Learning-Based Discrimination of Treatment-Resistant Schizophrenia Using Structural Brain Imaging: A Multi-Site Proof-of-Concept Study.
   Biol Psychiatry. 2026 Aug 22:S0006-3223(26)01489.
   PubMed     Abstract available
   
   
   
10. STEVENS C, Pincham H, Large M
    Cannabis Use and Age-Related Acceleration of Psychosis Onset: A Meta-Analysis.
    Biol Psychiatry. 2026 Aug 18:S0006-3223(26)01385.
    PubMed     Abstract available
    
    
    
11. SCHUURMANS IK, Smajlagic D, Baltramonaityte V, Malmberg ALK, et al
    Genetic Susceptibility to Neurodevelopmental Conditions Is Associated With Neonatal DNA Methylation Patterns in the General Population: An Individual Participant Data Meta-Analysis.
    Biol Psychiatry. 2026;100:414-425.
    PubMed     Abstract available
    
    
    
12. DARDANI C, Robinson JW, Havdahl A, Darrous L, et al
    Revisiting the Links Between Asthma and the Psychosis Spectrum: shared molecular mechanisms.
    Biol Psychiatry. 2026 Aug 6:S0006-3223(26)01462.
    PubMed     Abstract available
    
    
    July 2026
13. GONZALEZ-PENAS J, Schnack HG, Hernandez CR, Diaz-Caneja CM, et al
    Cortical Hub Vulnerability and Molecular Signatures of Sulcal Widening in Schizophrenia.
    Biol Psychiatry. 2026 Jul 29:S0006-3223(26)01437.
    PubMed     Abstract available
    
    
    
14. XUE X, Adelsheim Z, Gorczyca MT, Wei H, et al
    Mood and Psychosis Risk-Associated Genes Regulate Neuronal Circadian Rhythms Across the Transcriptome.
    Biol Psychiatry. 2026 Jul 27:S0006-3223(26)01436.
    PubMed     Abstract available
    
    
    
15. CHOPRA S, Holmes A, Segal A, Zhang XH, et al
    Differential Effects of Illness and Antipsychotics on Cortical Thinning in First-Episode Psychosis: A Randomized, Placebo-Controlled Magnetic Resonance Imaging Study.
    Biol Psychiatry. 2026 Jul 24:S0006-3223(26)01388.
    PubMed     Abstract available
    
    
    
16. SVENNINGSSON P
    Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With Schizophrenia.
    Biol Psychiatry. 2026;100:127-128.
    PubMed    
    
    
    
17. COHEN AS, Kirkpatrick B, Opler M, Tatsumi K, et al
    A Single, Interpretable Vocal Biomarker for Enriching Antipsychotic Clinical Trials.
    Biol Psychiatry. 2026;100:160-169.
    PubMed     Abstract available
    
    
    
18. LEE T, Eom K, Kim JJ, Lee Y, et al
    Translational Relevance of the MAM Model in Schizophrenia : A Systematic Review of Behavioral and Neurobiological Findings.
    Biol Psychiatry. 2026 Jul 8:S0006-3223(26)01383.
    PubMed     Abstract available
    
    
    June 2026
19. VOLPI T, Radhakrishnan R, Hird R, Naganawa M, et al
    Lower Muscarinic M1 Receptor Availability in Schizophrenia: In Vivo PET Evidence.
    Biol Psychiatry. 2026 Jun 12:S0006-3223(26)01316.
    PubMed     Abstract available
    
    
    
20. LE CLERC S, Bernard J, Choi J, Andreazza AC, et al
    Immunogenetic Variants in Major Mental and Neurodevelopmental Disorders.
    Biol Psychiatry. 2026;99:1002-1012.
    PubMed     Abstract available
    
    
    April 2026
21. RODRIGUEZ-SANCHEZ J, Hauke DJ, Pinotsis D, Berndt LCS, et al
    Biophysical modeling of excitation/inhibition balance and conversion to psychosis in the clinical high risk syndrome.
    Biol Psychiatry. 2026 Apr 21:S0006-3223(26)01191.
    PubMed     Abstract available
    
    
    
22. CHOPRA S
    Variability Is the Norm in Magnetic Resonance Imaging of Psychosis.
    Biol Psychiatry. 2026;99:515-516.
    PubMed    
    
    
    
23. ZHANG D, Wang J
    Successful Nonpharmacological Treatment Strategy for Cognitive Impairment in Individuals With Schizophrenia.
    Biol Psychiatry. 2026;99:511-512.
    PubMed    
    
    
    March 2026
24. XIAO Y, Li M, Liao J, Yan J, et al
    CINP: a causality-informed framework for generalizable and replicable neuroimaging prediction of antipsychotic response in schizophrenia.
    Biol Psychiatry. 2026 Mar 13:S0006-3223(26)01103.
    PubMed     Abstract available
    
    
    
25. XU B, Dijkzeul A, Zhang Y, Schuurmans IK, et al
    Genetic susceptibility to schizophrenia and the onset of brain developmental change in adolescence.
    Biol Psychiatry. 2026 Mar 13:S0006-3223(26)01104.
    PubMed     Abstract available
    
    
    
26. ZHOU H, Luo H, Gao L, Tang JY, et al
    A 20-year population-based follow-up study on the association between clozapine and hospitalization in people with treatment-resistant schizophrenia.
    Biol Psychiatry. 2026 Mar 4:S0006-3223(26)00092.
    PubMed     Abstract available
    
    
    February 2026
27. HAMILTON HK, Roach BJ, Nicholas S, Dembo R, et al
    Visual P300 and risk for psychosis onset in youth at clinical high-risk.
    Biol Psychiatry. 2026 Feb 28:S0006-3223(26)00090.
    PubMed     Abstract available
    
    
    January 2026
28. HWANG M, Brady R
    Cerebellar Pathophysiology in Schizophrenia: From Theory to Clinical Intervention.
    Biol Psychiatry. 2026;99:96-97.
    PubMed    
    
    
    
29. LICHENSTEIN SD
    Prenatal Cannabis Exposure Exacerbates Striatal Reward System Alterations Associated With Early Risk for Psychosis.
    Biol Psychiatry. 2026;99:102-103.
    PubMed    
    
    
    
30. BOUDEWYN MA
    Leveraging Large Language Models to Characterize Disrupted Speech Patterns in Schizophrenia.
    Biol Psychiatry. 2026;99:100-101.
    PubMed    
    
    
    November 2025
31. TURKOZER HB, Lizano P, Tamminga CA, Silverstein SM, et al
    Vision and Psychosis: A Clinical Translational Perspective.
    Biol Psychiatry. 2025 Nov 15:S0006-3223(25)01611.
    PubMed     Abstract available
    
    
    
32. VAN DER WALT K, Stein DJ, Zoghbi AW
    Genetic evidence for a neuro-immune model of schizophrenia.
    Biol Psychiatry. 2025 Nov 12:S0006-3223(25)01608.
    PubMed     Abstract available
    
    
    
33. FLETCHER PC, Robbins TW
    Shining a Light on the Earliest Symptoms of Psychosis.
    Biol Psychiatry. 2025;98:652-653.
    PubMed    
    
    
    
34. LEE CH
    Pleiotropy in Multitrait Genome-Wide Association Studies: Approaches and Insights From Schizophrenia-Cognition Analyses.
    Biol Psychiatry. 2025;98:650-651.
    PubMed    
    
    
    
35. POLLAK TA
    Autoimmune Psychosis: Progress, Problems, and the Path Ahead.
    Biol Psychiatry. 2025;98:648-649.
    PubMed    
    
    
    October 2025
36. WANG HR, Liu ZQ, Nomi JS, Schleifer CH, et al
    Multivariate Resting-State Functional Connectivity Features Linked to Transdiagnostic Psychopathology in Early Psychosis.
    Biol Psychiatry. 2025 Oct 29:S0006-3223(25)01573.
    PubMed     Abstract available
    
    
    
37. BERGINK V, Akbarian S, Byatt N, Chandra PS, et al
    Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert Consensus Statement on classification.
    Biol Psychiatry. 2025 Oct 22:S0006-3223(25)01536.
    PubMed     Abstract available
    
    
    
38. HOWES OD, Vano LJ, Petty AE, Rutigliano G, et al
    The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia.
    Biol Psychiatry. 2025 Oct 21:S0006-3223(25)01533.
    PubMed     Abstract available
    
    
    
39. MEMETOGLU O, Du F, Chouinard VA, Ongur D, et al
    Reductive Stress and Dysregulated Energy Metabolism in Schizophrenia: Mechanisms and Therapeutic Targets.
    Biol Psychiatry. 2025 Oct 16:S0006-3223(25)01528.
    PubMed     Abstract available
    
    
    
40. MA Y, Girdhar K, Hoffman GE, Fullard JF, et al
    Sex differences in brain cell-type specific chromatin accessibility in schizophrenia.
    Biol Psychiatry. 2025 Oct 8:S0006-3223(25)01517.
    PubMed     Abstract available
    
    
    September 2025
41. BRAH HS, Sran N, Sanghani S, Valmadrid L, et al
    Clinical Genetic Testing in Schizophrenia: A Systematic Review and Meta-Analysis.
    Biol Psychiatry. 2025 Sep 30:S0006-3223(25)01485.
    PubMed     Abstract available
    
    
    
42. MOLLON J, Schultz LM, Knowles EEM, Jacquemont S, et al
    Low Stability and Specificity of Polygenic Risk Scores for Major Psychiatric Disorders Limit Their Clinical Utility.
    Biol Psychiatry. 2025;98:476-484.
    PubMed     Abstract available
    
    
    
43. WANG SH, Feng YA, Lin MC, Cheng CF, et al
    Incorporating Polygenic Liability and Family History for Predicting Psychiatric Diseases in the Taiwan Biobank.
    Biol Psychiatry. 2025;98:485-493.
    PubMed     Abstract available
    
    
    August 2025
44. CIRSTIAN R, Forde NJ, Zhang G, Hellemann GS, et al
    Lifespan Normative Models of White Matter Fractional Anisotropy: Applications to Early Psychosis.
    Biol Psychiatry. 2025 Aug 1:S0006-3223(25)01379.
    PubMed     Abstract available
    
    
    July 2025
45. DI BIASE MA
    Ascribing Molecular Context to Functional Brain Changes in Psychosis.
    Biol Psychiatry. 2025;98:99-101.
    PubMed    
    
    
    
46. ZHANG T, Wei Y, Tang X, Xu L, et al
    Two-Month Cognitive Changes Enhance Prediction of Nonremission in Clinical High-Risk Individuals.
    Biol Psychiatry. 2025;98:175-185.
    PubMed     Abstract available
    
    
    
47. FORTEA A, Ortuno M, Masias M, Guasp M, et al
    Brain metabolite levels in the post-acute stage of anti-NMDA receptor encephalitis and schizophrenia: a longitudinal case-control study.
    Biol Psychiatry. 2025 Jul 12:S0006-3223(25)01316.
    PubMed     Abstract available
    
    
    
48. PENG X, Song C, Su Y, Kang D, et al
    Effects of Accelerated Intermittent Theta-Burst Stimulation Targeting the Superior Frontal Gyrus on Cognitive Function in Patients with Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial.
    Biol Psychiatry. 2025 Jul 11:S0006-3223(25)01310.
    PubMed     Abstract available
    
    
    
49. BUCIUMAN MO, Haas SS, Antonucci LA, Sarisik E, et al
    From Snapshots to Stable Outcomes: rs-fMRI-based Prognosis of Functioning in Patients with Psychosis Risk or Recent-Onset Depression.
    Biol Psychiatry. 2025 Jul 9:S0006-3223(25)01308.
    PubMed     Abstract available
    
    
    
50. CARRION RE, John M, Dorvil S, Auther A, et al
    Exploring the pathways between early auditory processing, processing speed, social cognition, and negative symptoms on social functioning in individuals at clinical high risk for psychosis: A structural equation modeling approach.
    Biol Psychiatry. 2025 Jul 7:S0006-3223(25)01309.
    PubMed     Abstract available
    
    
    
51. MANCINI V, Delavari F, Eom TY, Zakharenko SS, et al
    How does altered function of the hippocampus contribute to the development of psychosis?
    Biol Psychiatry. 2025 Jul 5:S0006-3223(25)01296.
    PubMed     Abstract available
    
    
    
52. CAO H, Argyelan M, Yan J, Velioglu HA, et al
    Mapping cerebellar connectivity to cognition in psychosis: Convergent evidence from fMRI and TMS.
    Biol Psychiatry. 2025 Jul 3:S0006-3223(25)01297.
    PubMed     Abstract available
    
    
    June 2025
53. CASTELNOVO A, D'Agostino A, Mayeli A, Albantakis L, et al
    Sleep spindle abnormalities as neurophysiological biomarkers of Schizophrenia spectrum disorders: From cellular mechanisms and neural circuits to clinical implications.
    Biol Psychiatry. 2025 Jun 25:S0006-3223(25)01274.
    PubMed     Abstract available
    
    
    
54. MURRAY RM, Egerton A, Gao Y, Grace AA, et al
    Why is Clozapine uniquely Effective in Treatment Resistant Schizophrenia?
    Biol Psychiatry. 2025 Jun 23:S0006-3223(25)01270.
    PubMed     Abstract available
    
    
    
55. AWADA J, Delavari F, Bolton TAW, Alouf F, et al
    A Longitudinal and Reproducible Anti-coactivation Pattern Between the Cerebellum and the Ventral Tegmental Area Relates to Apathy in Schizophrenia.
    Biol Psychiatry. 2025 Jun 18:S0006-3223(25)01252.
    PubMed     Abstract available
    
    
    
56. SHARPE V, Mackinley M, Nour Eddine S, Wang L, et al
    Selective insensitivity to global vs. local linguistic context in speech produced by patients with untreated psychosis and positive thought disorder.
    Biol Psychiatry. 2025 Jun 10:S0006-3223(25)01243.
    PubMed     Abstract available
    
    
    May 2025
57. LELLA A, Antonucci LA, Passiatore R, Bellantuono L, et al
    Thalamo-cortical structural co-variation networks are related to familial risk for schizophrenia in the context of lower nuclei volume estimates in patients: an ENIGMA study.
    Biol Psychiatry. 2025 May 7:S0006-3223(25)01178.
    PubMed     Abstract available
    
    
    April 2025
58. VYAZOVSKIY VV, Bannerman DM
    Preclinical models for schizophrenia and sleep oscillations: from biomarkers to mechanisms.
    Biol Psychiatry. 2025 Apr 8:S0006-3223(25)01115.
    PubMed    
    
    
    March 2025
59. ODKHUU S, Tang X, Kim WS, Wei Y, et al
    Brain Network Resilience and Cognitive Function in Patients with First Episode Schizophrenia Spectrum Disorders.
    Biol Psychiatry. 2025 Mar 30:S0006-3223(25)01104.
    PubMed     Abstract available
    
    
    
60. WANG D, Li D, Dang X, Mu C, et al
    Mendelian randomization reveals causalities between DNA methylation and schizophrenia.
    Biol Psychiatry. 2025 Mar 27:S0006-3223(25)01100.
    PubMed     Abstract available
    
    
    
61. ROMERO C, de Leeuw C, Schipper M, Maciel BAPC, et al
    Immune-developmental processes contribute to schizophrenia risk: insights from a genetic overlap study with height.
    Biol Psychiatry. 2025 Mar 10:S0006-3223(25)01018.
    PubMed     Abstract available
    
    
    February 2025
62. MOURGUES-CODERN C, Benrimoh D, Gandhi J, Farina EA, et al
    Emergence and dynamics of delusions and hallucinations across stages in early psychosis.
    Biol Psychiatry. 2025 Feb 26:S0006-3223(25)00990.
    PubMed     Abstract available
    
    
    
63. BHATTACHARYYA U, John J, Lencz T, Lam M, et al
    Dissecting Schizophrenia Biology Using Pleiotropy with Cognitive Genomics.
    Biol Psychiatry. 2025 Feb 22:S0006-3223(25)00989.
    PubMed     Abstract available
    
    
    
64. TEBARTZ VAN ELST L, Runge K, Meyer PT, Urbach H, et al
    The Neuropsychiatric Checklist for Autoimmune Psychosis: A Narrative Review.
    Biol Psychiatry. 2025 Feb 21:S0006-3223(25)00988.
    PubMed     Abstract available
    
    
    
65. AKKOUH IA, Osete JR, Szabo A, Andreassen OA, et al
    Neurobiological perturbations in bipolar disorder compared to schizophrenia - evidence from cell cultures and brain organoids.
    Biol Psychiatry. 2025 Feb 19:S0006-3223(25)00110.
    PubMed     Abstract available
    
    
    
66. KNIGHT SR, Abbasova L, Zeighami Y, Hansen JY, et al
    Transcriptional and neurochemical signatures of cerebral blood flow alterations in schizophrenia and individuals at clinical high-risk for psychosis.
    Biol Psychiatry. 2025 Feb 7:S0006-3223(25)00076.
    PubMed     Abstract available
    
    
    January 2025
67. FAN L, Carrico S, Zhu Y, Ackerman RA, et al
    Transcranial Direct Current Stimulation Improves Paranoia and Social Functioning in Schizophrenia: A Randomized Clinical Trial.
    Biol Psychiatry. 2025 Jan 22:S0006-3223(25)00053.
    PubMed     Abstract available
    
    
    
68. DIENEL SJ, Wade KL, Fish KN, Lewis DA, et al
    Alterations in Prefrontal Cortical Somatostatin Neurons in Schizophrenia: Evidence for Weaker Inhibition of Pyramidal Neuron Dendrites.
    Biol Psychiatry. 2025 Jan 21:S0006-3223(25)00052.
    PubMed     Abstract available
    
    
    
69. BUCK J, Horga G
    Increasing the Interpretability of Psychosis Models.
    Biol Psychiatry. 2025;97:99-101.
    PubMed    
    
    
    
70. PEARLSON GD
    Clinical Phenotypes Associated With White Matter Microstructural Abnormalities Across Early Psychoses.
    Biol Psychiatry. 2025;97:102-103.
    PubMed    
    
    
    November 2024
71. SANTONI M, Pistis M
    Maternal Immune Activation and Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia.
    Biol Psychiatry. 2024 Nov 29:S0006-3223(24)01783.
    PubMed     Abstract available
    
    
    
72. ALAMIA A, Gordillo D, Chkonia E, Roinishvili M, et al
    Oscillatory traveling waves provide evidence for predictive coding abnormalities in schizophrenia.
    Biol Psychiatry. 2024 Nov 28:S0006-3223(24)01782.
    PubMed     Abstract available
    
    
    
73. LIZANO P, Velez-Perez E
    Multimodal Retinal Imaging Findings in Schizophrenia Spectrum Disorders.
    Biol Psychiatry. 2024;96:769-771.
    PubMed    
    
    
    
74. HE Y, Zhao L, Chen X
    Tracing the Trajectory: Polyunsaturated Fatty Acids and Early Adult Psychosis.
    Biol Psychiatry. 2024;96:768.
    PubMed    
    
    
    October 2024
75. CHENGAPPA KNR, Shekhar A
    Novel Ideas for Drug Discovery in the Treatment of People With Schizophrenia.
    Biol Psychiatry. 2024;96:624-626.
    PubMed    
    
    
    September 2024
76. STAGLIN B
    The Future of Schizophrenia Care: A Lived Experience-Based Call for Innovation.
    Biol Psychiatry. 2024 Sep 23:S0006-3223(24)01613.
    PubMed    
    
    
    
77. HECKERS S, Feola B
    Perceived Stress and Hippocampal Volume in Psychosis.
    Biol Psychiatry. 2024;96:329-330.
    PubMed    
    
    
    
78. YOHN SE, Breier A, Paul SM
    Altered Vesicular Acetylcholine Transporter Availability in Schizophrenia: Association With Positive Symptoms and Cognitive Impairment.
    Biol Psychiatry. 2024;96:324-325.
    PubMed    
    
    
    August 2024
79. MIKUS N, Lamm C, Mathys C
    Computational phenotyping of aberrant belief updating in individuals with schizotypal traits and schizophrenia.
    Biol Psychiatry. 2024 Aug 30:S0006-3223(24)01554.
    PubMed     Abstract available
    
    
    
80. SEHATPOUR P, Kantrowitz JT
    Finding the right dose: NMDAR modulating treatments for cognitive and plasticity deficits in schizophrenia and the role of pharmacodynamic target engagement.
    Biol Psychiatry. 2024 Aug 30:S0006-3223(24)01552.
    PubMed     Abstract available
    
    
    
81. SCHLEIFER CH, Chang SE, Amir CM, O'Hora KP, et al
    Unique functional neuroimaging signatures of genetic versus clinical high risk for psychosis.
    Biol Psychiatry. 2024 Aug 22:S0006-3223(24)01538.
    PubMed     Abstract available
    
    
    
82. LIDDLE PF, Sami MB
    The mechanisms of persisting disability in schizophrenia: imprecise predictive coding via cortico-striatal-thalamo-cortical loop dysfunction.
    Biol Psychiatry. 2024 Aug 22:S0006-3223(24)01535.
    PubMed     Abstract available
    
    
    
83. CHENG Y, Cai H, Liu S, Yang Y, et al
    Brain network localization of gray matter atrophy, neurocognitive and social cognitive dysfunction in schizophrenia.
    Biol Psychiatry. 2024 Aug 3:S0006-3223(24)01489.
    PubMed     Abstract available
    
    
    
84. GAO Z, Lui S
    Combining Radiomics With Connectomics: A Promising New Approach to Characterize Dysconnectivity in Schizophrenia.
    Biol Psychiatry. 2024;96:162-163.
    PubMed    
    
    
    
85. JEFSEN OH, Holde K, McGrath JJ, Rajagopal VM, et al
    Polygenic Risk of Mental Disorders and Subject-Specific School Grades.
    Biol Psychiatry. 2024;96:222-229.
    PubMed     Abstract available
    
    
    July 2024
86. CHOPRA S, Levi PT, Holmes A, Orchard ER, et al
    Brain-wide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naive First Episode Psychosis.
    Biol Psychiatry. 2024 Jul 26:S0006-3223(24)01483.
    PubMed     Abstract available
    
    
    
87. WARD HB, Beermann A, Xie J, Yildiz G, et al
    Robust Brain Correlates of Cognitive Performance in Psychosis and its Prodrome.
    Biol Psychiatry. 2024 Jul 18:S0006-3223(24)01460.
    PubMed     Abstract available
    
    
    
88. FULFORD D, Marsch LA, Pratap A
    Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia.
    Biol Psychiatry. 2024 Jul 1:S0006-3223(24)01430.
    PubMed     Abstract available
    
    
    June 2024
89. GANAPATHIRAJU MK, Triptish B, Deshpande S, Wesesky M, et al
    Schizophrenia interactome derived repurposable drugs and randomized control trials of two candidates.
    Biol Psychiatry. 2024 Jun 29:S0006-3223(24)01426.
    PubMed     Abstract available
    
    
    
90. VANO LJ, McCutcheon RA, Rutigliano G, Kaar SJ, et al
    Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-sensitive MRI and [18F]-DOPA PET Study.
    Biol Psychiatry. 2024 Jun 26:S0006-3223(24)01417.
    PubMed     Abstract available
    
    
    
91. CHANG K, Jian X, Wu C, Gao C, et al
    The Contribution of Mosaic Chromosomal Alterations to Schizophrenia.
    Biol Psychiatry. 2024 Jun 26:S0006-3223(24)01419.
    PubMed     Abstract available
    
    
    
92. WANG HR, Liu ZQ, Nakua H, Hegarty CE, et al
    Decoding Early Psychoses: Unraveling Stable Microstructural Features Associated with Psychopathology Across Independent Cohorts.
    Biol Psychiatry. 2024 Jun 20:S0006-3223(24)01391.
    PubMed     Abstract available
    
    
    
93. JIAO X, Hu Q, Tang Y, Zhang T, et al
    Abnormal Global Cortical Responses in Drug-naive Patients with Schizophrenia following Orbitofrontal Cortex Stimulation: A Concurrent TMS-EEG Study.
    Biol Psychiatry. 2024 Jun 7:S0006-3223(24)01364.
    PubMed     Abstract available
    
    
    
94. KRAKOWSKI K, Oliver D, Arribas M, Stahl D, et al
    Dynamic and transdiagnostic risk calculator based on Natural Language Processing for the prediction of psychosis in secondary mental health care: development and internal-external validation cohort study.
    Biol Psychiatry. 2024 Jun 7:S0006-3223(24)01361.
    PubMed     Abstract available
    
    
    
95. KOCHUNOV PV, Hong LE
    Is Schizophrenia a Disorder of Accelerated Whole-System Aging?
    Biol Psychiatry. 2024;95:988-989.
    PubMed    
    
    
    May 2024
96. HOWES OD, Dawkins E, Lobo MC, Kaar SJ, et al
    New drug treatments for schizophrenia: a review of approaches to target circuit dysfunction.
    Biol Psychiatry. 2024 May 28:S0006-3223(24)01349.
    PubMed     Abstract available
    
    
    
97. LU T, Chen Y, Yoshiji S, Ilboudo Y, et al
    Circulating metabolite abundances associated with risks of bipolar disorder, schizophrenia, and depression: a Mendelian randomization study.
    Biol Psychiatry. 2024 May 3:S0006-3223(24)01285.
    PubMed     Abstract available
    
    
    April 2024
98. BOUDRIOT E, Gabriel V, Popovic D, Pingen P, et al
    Signature of altered retinal microstructures and electrophysiology in schizophrenia spectrum disorders is associated with disease severity and polygenic risk.
    Biol Psychiatry. 2024 Apr 26:S0006-3223(24)01262.
    PubMed     Abstract available
    
    
    
99. MONGAN D, Perry BI, Healy C, Susai SR, et al
    Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis-spectrum outcomes in early adulthood.
    Biol Psychiatry. 2024 Apr 15:S0006-3223(24)01229.
    PubMed     Abstract available
    
    
    
100. KIM J, Park IH
     Identifying an Early Neuropathological Mechanism in Schizophrenia With Brain Organoids.
     Biol Psychiatry. 2024;95:608-610.
     PubMed    
     
     
     
101. RADHAKRISHNAN R
     In Vivo Synaptic Density in Early Schizophrenia: Are There No Differences or Are They Too Small to Detect?
     Biol Psychiatry. 2024;95:605-607.
     PubMed    
     
     
     
102. STEIN F, Gruber M, Mauritz M, Brosch K, et al
     Brain Structural Network Connectivity of Formal Thought Disorder Dimensions in Affective and Psychotic Disorders.
     Biol Psychiatry. 2024;95:629-638.
     PubMed     Abstract available
     
     
     March 2024
103. PAUL SM, Yohn SE, Brannan SK, Neugebauer NM, et al
     Muscarinic Receptor Activators as Novel Treatments for Schizophrenia.
     Biol Psychiatry. 2024 Mar 25:S0006-3223(24)01173.
     PubMed     Abstract available
     
     
     
104. GONZALEZ-PENAS J, Alloza C, Brouwer R, Diaz-Caneja CM, et al
     Accelerated Cortical Thinning in Schizophrenia is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders.
     Biol Psychiatry. 2024 Mar 21:S0006-3223(24)01170.
     PubMed     Abstract available
     
     
     February 2024
105. MEHTA UM, Ithal D, Roy N, Shekhar S, et al
     Posterior Cerebellar Resting-State Functional Hypoconnectivity: A Neural Marker of Schizophrenia across Different Stages of Treatment Response.
     Biol Psychiatry. 2024 Feb 7:S0006-3223(24)00076.
     PubMed     Abstract available
     
     
     
106. WEINSTEIN JJ, Moeller SJ, Perlman G, Gil R, et al
     Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: a PET study using [(18)F]-VAT.
     Biol Psychiatry. 2024 Feb 1:S0006-3223(24)00062.
     PubMed     Abstract available
     
     
     January 2024
107. MAXIMO JO, Armstrong WP, Kraguljac NV, Lahti AC, et al
     Higher-Order Intrinsic Brain Network Trajectories after Antipsychotic Treatment in Medication-Naive First Episode Psychosis Patients.
     Biol Psychiatry. 2024 Jan 23:S0006-3223(24)00037.
     PubMed     Abstract available
     
     
     
108. PRELLER KH, Scholpp J, Wunder A, Rosenbrock H, et al
     Neuroimaging biomarkers for drug discovery and development in Schizophrenia.
     Biol Psychiatry. 2024 Jan 23:S0006-3223(24)00036.
     PubMed     Abstract available
     
     
     
109. MARIANO M, Rossetti I, Maravita A, Paulesu E, et al
     Sensory attenuation deficit and auditory hallucinations in schizophrenia: a causal mechanism or a risk factor? Evidence from meta-analyses on N1 ERP-EEG component.
     Biol Psychiatry. 2024 Jan 19:S0006-3223(24)00035.
     PubMed     Abstract available
     
     
     
110. MA Y, Bendl J, Hartley BJ, Fullard JF, et al
     Activity-Dependent Transcriptional Program in NGN2+ Neurons Enriched for Genetic Risk for Brain-Related Disorders.
     Biol Psychiatry. 2024;95:187-198.
     PubMed     Abstract available
     
     
     
111. DING H, Zhang Y, Xie Y, Du X, et al
     Individualized texture similarity network in schizophrenia.
     Biol Psychiatry. 2024 Jan 11:S0006-3223(24)00029.
     PubMed     Abstract available
     
     
     December 2023
112. CLIFTON NE, Lin JQ, Holt CE, O'Donovan MC, et al
     Enrichment of the local synaptic translatome for genetic risk associated with schizophrenia and autism spectrum disorder.
     Biol Psychiatry. 2023 Dec 14:S0006-3223(23)01764.
     PubMed     Abstract available
     
     
     
113. ABERIZK K, Addington JM, Bearden CE, Cadenhead KS, et al
     Relations of Lifetime Perceived Stress and Basal Cortisol with Hippocampal Volume among Healthy Adolescents and those at Clinical High-Risk for Psychosis: A Structural Equation Modeling Approach.
     Biol Psychiatry. 2023 Dec 11:S0006-3223(23)01759.
     PubMed     Abstract available
     
     
     
114. IRAJI A, Chen J, Lewis N, Faghiri A, et al
     Spatial Dynamic Subspaces Encode Sex-Specific Schizophrenia Disruptions in Transient Network Overlap and its Links to Genetic Risk.
     Biol Psychiatry. 2023 Dec 7:S0006-3223(23)01756.
     PubMed     Abstract available
     
     
     
115. DOGRA S, Aguayo C, Xiang Z, Putnam J, et al
     Activation of metabotropic glutamate receptor 3 modulates thalamo-accumbal transmission and rescues schizophrenia-like physiological and behavioral deficits.
     Biol Psychiatry. 2023 Dec 5:S0006-3223(23)01753.
     PubMed     Abstract available
     
     
     
116. SEN P, Prandovszky E, Honkanen JK, Chen O, et al
     Dysregulation of microbiota in first episode psychosis patients were associated with symptom severity and treatment response.
     Biol Psychiatry. 2023 Dec 5:S0006-3223(23)01751.
     PubMed     Abstract available
     
     
     November 2023
117. ST GEORGE-HYSLOP F, Haneklaus M, Kivisild T, Livesey FJ, et al
     Loss of CNTNAP2 Alters Human Cortical Excitatory Neuron Differentiation and Neural Network Development.
     Biol Psychiatry. 2023;94:780-791.
     PubMed     Abstract available
     
     
     
118. CANNON TD
     On the clinical utility of individualized prediction models for psychosis in at risk youth.
     Biol Psychiatry. 2023 Nov 8:S0006-3223(23)01696.
     PubMed    
     
     
     
119. CASPI A, Shireby G, Mill J, Moffitt TE, et al
     Accelerated pace of aging in schizophrenia: Five case-control studies.
     Biol Psychiatry. 2023 Nov 2:S0006-3223(23)01693.
     PubMed     Abstract available
     
     
     
120. HARVANEK ZM, Boks MP, Vinkers CH, Higgins-Chen AT, et al
     The Cutting Edge of Epigenetic Clocks: In Search of Mechanisms Linking Aging and Mental Health.
     Biol Psychiatry. 2023;94:694-705.
     PubMed     Abstract available
     
     
     October 2023
121. ROGDAKI M
     From Gene to Brain and Behavior: Excitatory and Inhibitory Imbalance and Psychosis in Individuals With 22q11.2 Deletion Syndrome.
     Biol Psychiatry. 2023;94:526-527.
     PubMed    
     
     
     September 2023
122. AKKOUH IA, Ueland T, Szabo A, Hughes T, et al
     Longitudinal transcriptomic analysis of human cortical spheroids identifies axonal dysregulation in the prenatal brain as a mediator of genetic risk for schizophrenia.
     Biol Psychiatry. 2023 Sep 1:S0006-3223(23)01529.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum